Breast cancer: multicentric, nipple involvement · Axillary lymph nodes Summary Background: Axillary lymph node dissection plays an important role in breast cancer management in terms of staging, prediction of prognosis, determination of adjuvant therapy, and local control of the primary tumor. The objective of this study was to evaluate the axillary lymph node involvement in multicentric breast tumors and breast tumors with nipple involvement in comparison with unifocal tumors. Patients and Methods: We reviewed the records of 267 patients with stage I or IIA disease. The rates of axillary lymph node metastasis (ALNM) in patients with unifocal tumors, multicentric tumors, or nipple involvement were compared. Results: 209 (78%) patients had unifocal tumors, 24 (8%) had multicentric tumors, and 34 (12%) had nipple involvement. The incidence of ALNM was 9.76% in patients with unifocal tumors, 24.84% in patients with multicentric tumors, and 36.71% in patients with nipple involvement. Hence, the incidence of ALNM was significantly higher in patients with nipple involvement or multicentric tumors than in patients with unifocal tumors. Conclusion: Our data suggest that compared to unifocal tumors, breast tumors with nipple involvement or multiple foci show a significantly higher incidence of ALNM which is a predictor of a poor prognosis.
Introduction
Surgical treatment is still the primary treatment modality in most patients with breast cancer. Axillary lymph node dissection following mastectomy or breast conserving surgery has been widely used for disease staging, prediction of prognosis, local tumor control, and determination of adjuvant treatment [1, 2] . The axillary node status, independent of other factors, is the best prognostic marker in patients with breast cancer, and is hence the most important procedure to provide infor- mation about the prognosis [3] [4] [5] . Koscielny et al. [3] showed a correlation between tumor size and the number of positive axillary lymph nodes. However, it has also been stated that this correlation is lost when the size of the primary tumor is less than 3.6 cm in diameter. Multicentric breast tumors are defined by the presence of 2 or more physically separate tumors in more than 1 quadrant of the same breast. The prevalence of multicentricity reported varies from to 13 to 65% depending on the definition of multicentricity and the sampling method used to obtain mastectomy specimens [6] . Compared with unifocal tumors, multicentric breast tumors have a higher frequency of lymph node mestastasis [7] . Another tumor characteristic associated with increased axillary lymph node involvement is nipple involvement [8] which has been reported to range from 0 to 58% [9] . However, we were unable to find a study which compared the rate of axillary lymph node involvement in breast tumors with multiple foci and breast tumors with nipple involvement. In the present study, we therefore explored the frequency of axillary lymph node involvement in unifocal breast tumors, multicentric breast tumors, and breast tumors involving the nipple.
Patients and Methods
Data pertaining to 850 patients who underwent surgery for breast cancer at the University Hospital of Selcuk University (Meram, Konya, Turkey) between 2006 and 2010 were collected, and the records of 267 female patients who met the study criteria were retrospectively examined. The total number of dissected lymph nodes and the number of metastatic lymph nodes were documented separately and statistically analyzed. Patients were divided into 3 groups: unifocal breast tumors, multicentric breast tumors, and breast tumors with nipple involvement. 2 or more physically separate tumors in different quadrants of the breast were defined as multicentric tumors. Nipple involvement was defined by the presence of tumor in the pathologic examination of the relevant specimen. All patients had stage I or IIA disease according to the TNM classification. All patients had tumors measuring less than 5 cm, and a histopathological diagnosis of infiltrative ductal carcinoma. All surgeries were performed by the same surgical team, and the dissection of the axillary lymph nodes from the tumor specimens was performed by the same pathologist. Patients in whom less than 10 lymph nodes were dissected and those in whom axillary dissection was not performed due to negative sentinel lymph node biopsy were excluded from the study [8] . In our clinic, adequate lymph node dissection is defined as the removal of 10 or more lymph nodes. All tumors were located in the upper quadrant of the breast, and had the same hormone receptor status. The chi square test was used to examine statistical differences between the 3 groups.
Results
A total of 267 patients aged between 23 and 78 years (median 46 years, 20/standard deviation 11, 97) were included in this study. The final pathological evaluation revealed unifocal tumors in 209 (78%) patients, multicentric tumors in 24 (8%) patients, and nipple involvement in 34 (12%) patients ( Cakir/Tekin/Kücükkartallar/Vatansev/ Aksoy/Kartal/Tuncer [10] [11] [12] . In our study, we examined axillary lymph node involvement for tumors with similar histolopathologic characteristics and measuring 5 cm or less. Many studies have found a correlation between tumor size and ALNM. 10-year survival rates for patients with breast cancer have been reported to be over 70% for patients without ALNM. However, this rate decreases to 50% in patients with 1-3 ALNM, 35% in patients with 4-10 ALNM, 20% in patients with 11-20 ALNM, and 17%in patients with more than 20 ALNM [13] . Based on this data, we can conclude that the prognosis is less favorable in patients with multicentric breast cancer or breast cancer involving the nipple [13] . Our results showed that by controlling for tumor size, breast cancer with multiple foci or nipple involvement has a significantly higher frequency of ALNM than unifocal tumors of the same size.
The most important predictors of 10-and 20-year survival are distant metastasis and the number of metastatic axillary lymph nodes. However, physical examination alone is not sufficient in determining the extent of ALNM and predicting survival and yields a 25-31% false-positive and 23-33% falsenegative rate.
Several factors are associated with axillary lymph node involvement in patients with breast cancer. These factors include tumor size, histological tumor characteristics, lymphatic or vascular invasion, tumor grade, neovascularization of the tumor, S phase fraction, DNA aneuploidy, and extensive intraductal component [13] [14] [15] . The most important and best proven of the above factors, which also gives an idea about prognosis, is tumor size. In our study, tumor size was standardized by only including stage I and IIA tumors. Also, only infiltrative ductal carcinomas were included which made this study more optimal.
Almost 50% of patients with breast cancer can now be diagnosed before stage II. The rate of axillary lymph node involvement at the time of diagnosis is about 30-35% [16, 17] . The incidence of ALNM is 0-1% in patients with ductal carcinoma in situ, 3-5% in patients at stage IA, 10-17% in patients at stage T1B, 23-48% in patients at stage T2, and 29-64% in patients at stage T3 [17, 18] . We detected that breast tumors with multiple foci or nipple involvement had a higher frequency of ALNM than unifocal tumors, and breast tumors with nipple involvement were associated with a higher ALNM frequency than multifocal tumors (p < 0.001).
In summary, breast tumors with a higher rate of axillary lymph node metastasis have a poorer prognosis. Our results showed that breast tumors with nipple involvement and multicentric tumors have a significantly higher incidence of ALNM than unifocal tumors, which leads to the conclusion that these patient groups carry a less favorable prognosis.
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